ACVR2A Antilichaam / Activa receptor type 2A

ACVR2A is a receptor protein that belongs to the TGF-beta superfamily, which is known for its role in controlling cell growth, differentiation, and development. Studies have shown that mutations in the ACVR2A gene can lead to a variety of health conditions, including certain types of cancer and developmental disorders. One of the most intriguing aspects of ACVR2A is its potential as a therapeutic target. By developing drugs that can modulate the activity of ACVR2A, researchers may be able to treat a range of diseases, from cancer to muscular dystrophy. Recent studies have even suggested that targeting ACVR2A could help improve outcomes for patients with certain types of cancer.

Western blot: 1:500-1:1000

P27037

Human, Mouse

A portion of amino acids 2-29 from the human protein was used as the immunogen for the ACVR2A antibody.

WB

Purified

This ACVR2A antibody is available for research use only.

Aliquot the ACVR2A antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.

In 1X PBS, pH 7.4, with 0.09% sodium azide

The stated application concentrations are suggested starting points. Titration of the ACVR2A antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Western blot testing of human fetal liver tissue lysate with ACVR2A antibody. Predicted molecular weight ~58 kDa.